1.In CKD patients, cardiovascular risk rises proportionally to the decline of renal function and becomes remarkable when glomerular filtration rate (GFR) is below 60 ml/min/1.73m~2 .The impact of cardiovascular complications is so important that the risk for fatal and nonfatal cardiovascular events overcomes that for renal disease progression.
随着肾功能的减退,慢性肾脏病(CKD)患者的心血管风险逐渐增加,当肾小球滤过率低于60ml/min/1.73m~2时更加突出,心血管并发症导致患者发生心血管事件的可能性甚至超过了肾脏病进展本身。
2.Objective: To investigate prevalence rates and clustering of cardiovascular risk factor in the Bortala Prefecture of Xinjiang Kazaka, Mongol People,to find the chacracteristics of cardiovascular risk factor in multi-national region and provide basis for prevention and treatment of cardiovascular disease.
目的：探讨新疆博尔塔拉州哈萨克族和蒙古族心血管主要危险因素发生情况及聚集情况，发现多民族聚集区危险因素的特征，为预防和治疗心血管病提供依据。
3.The basic pathology of cerebrovascular and cardiovascular diseases is atherosclerosis (AS), while dyslipidemia is closely correlated with cardiovascular disease. Lipid metabolism dysfunction induced AS is the important risk factor in the occurrence and development of cerebrovascular and cardiovascular diseases.
心脑血管疾病的病理基础是动脉粥样硬化(atherosclerosis,AS),而脂类代谢与心血管疾病密切相关,脂质代谢紊乱所致的AS是引起心脑血管疾病发生、发展的重要危险因素。
4.High cardiovascular risk patients are defined as those who developed cardiovascular events (coronary heart disease,ischemic stroke and transient ischemic attack) before or those who have two or more cardiovascular risk factors(more than 50 years old,smoking,obesity,hypertension,diabetes mellitus and hyperlipidemia).
高危人群定义为既往发生过心脑血管事件(冠心病、缺血性脑卒中、短暂性脑缺血发作)或具有两种以上心血管危险因素(年龄≥50岁、吸烟、肥胖、高血压病、糖尿病、高脂血症)的人群。
5.Cardiovascular disease is one of the most dangerous threats to human health. The application of dynamic electrocardiogram (DCG) is essential for the clinical diagnosis of cardiovascular disease.
心血管疾病是威胁人类健康的主要疾病之一，动态心电图是临床诊断心血管疾病的重要办法。
6.219 cases of cardiovascular patients were studied. Defined dayly dose (DDD) and drug use index (DUI), which are used by Drug Utilization Research Group of WHO, were used as indicators to monitor the use of drugs for cardiovascular patients and evaluate the use of the drugs by doctors in their clinical practice with an attempt to find the tendency of use of these drugs.
通过对219例心血管患者病例调查,采用WHO药物利用研究组“限定日剂量”(DDD)和“药物利用指数”(DUI)作为指标,对心血管疾病用药进行监测,评价临床医生用药的合理性,探讨用药的流行趋势.
7.A new release of an integrated cardiovascular information system now integrates exam results from all major cardiology subspecialties—interventional cardiology, cardiovascular ultrasound, electrocardiogram (ECG), nuclear cardiology, cardiac computed tomography (CT), cardiac magnetic resonance imaging (MRI), and electrophysiology (EP).
一种刚投放的综合心血管信息系统，现在整合所有心血管专业的检查结果，包括心脏介入、心血管超声、心电图(ECG)、核放射心脏病学、计算机断层扫描(CT)心脏核磁共振(MRI)和电生理(EP)学。
8.Clinical Compare between Brain Cardiovascular Stroke (BCS) of 32 Patients and Cardiovascular Brain Stroke (CBS) of 30 Patients
32例脑心卒中与30例心脑卒中的临床比较
9.Overview showed that stroke was reduced by 36% (95% CI 25%～46%, P
脑卒中危险降低36%(95%CI为25%~46%,P
10.Objective :To compare cardiovascular disease risk between overweight and nonoverweight hypertensives. Method:A total of 3 050 hypertensives (SBP≥140 mmHg, DBP≥90 mmHg or on medication in 2 weeks) from a community based large multicenter epidemiology survey were divided into overweight (BMI≥25 kg/m 2) and non overweight (BMI<25 kg/m 2) for a comparison in cardiovascular risk factors.
本研究以3050例来自人群流行病学调查所得高血压患者［收缩压≥140mmHg（1mmHg＝0．133kPa），舒张压≥90mmHg或在二周内服用降压药者］作为研究对象，按体重指数（BMI）＜25kg／m2和BMI≥25kg／m2分为非超重高血压组和超重高血压组。
